- Report
- May 2025
- 187 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 200 Pages
Global
From €2229EUR$2,490USD£1,899GBP
- Report
- February 2025
- 200 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- April 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- June 2025
- 377 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- May 2025
- 186 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- May 2025
- 181 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- April 2025
- 175 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- April 2025
- 175 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- April 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- March 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- June 2025
- 73 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 72 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 373 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 279 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 194 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 490 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 278 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- June 2025
- 262 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- October 2024
- 200 Pages
Global
From €4430EUR$4,949USD£3,774GBP

The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more